Literature DB >> 33494253

Efficacy of Posidonia oceanica Extract against Inflammatory Pain: In Vivo Studies in Mice.

Laura Micheli1, Marzia Vasarri2, Emanuela Barletta2, Elena Lucarini1, Carla Ghelardini1, Donatella Degl'Innocenti2,3, Lorenzo Di Cesare Mannelli1.   

Abstract

Posidonia oceanica (L.) Delile is traditionally used for its beneficial properties. Recently, promising antioxidant and anti-inflammatory biological properties emerged through studying the in vitro activity of the ethanolic leaves extract (POE). The present study aims to investigate the anti-inflammatory and analgesic role of POE in mice. Inflammatory pain was modeled in CD-1 mice by the intraplantar injection of carrageenan, interleukin IL-1β and formalin. Pain threshold was measured by von Frey and paw pressure tests. Nociceptive pain was studied by the hot-plate test. POE (10-100 mg kg-1) was administered per os. The paw soft tissue of carrageenan-treated animals was analyzed to measure anti-inflammatory and antioxidant effects. POE exerted a dose-dependent, acute anti-inflammatory effect able to counteract carrageenan-induced pain and paw oedema. Similar anti-hyperalgesic and anti-allodynic results were obtained when inflammation was induced by IL-1β. In the formalin test, the pre-treatment with POE significantly reduced the nocifensive behavior. Moreover, POE was able to evoke an analgesic effect in naïve animals. Ex vivo, POE reduced the myeloperoxidase activity as well as TNF-α and IL-1β levels; further antioxidant properties were highlighted as a reduction in NO concentration. POE is the candidate for a new valid strategy against inflammation and pain.

Entities:  

Keywords:  CD-1 mice; P. oceanica; inflammation; pain

Mesh:

Substances:

Year:  2021        PMID: 33494253      PMCID: PMC7909763          DOI: 10.3390/md19020048

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  34 in total

Review 1.  A brief comparison of the pathophysiology of inflammatory versus neuropathic pain.

Authors:  Qinghao Xu; Tony L Yaksh
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

2.  In vitro anti-glycation activity of the marine plant Posidonia oceanica (L.) Delile.

Authors:  Marzia Vasarri; Emanuela Barletta; Matteo Ramazzotti; Donatella Degl'Innocenti
Journal:  J Ethnopharmacol       Date:  2020-05-11       Impact factor: 4.360

3.  Widespread pain reliever profile of a flower extract of Tanacetum parthenium.

Authors:  Lorenzo Di Cesare Mannelli; Barbara Tenci; Matteo Zanardelli; Anna Maidecchi; Andrea Lugli; Luisa Mattoli; Carla Ghelardini
Journal:  Phytomedicine       Date:  2015-05-27       Impact factor: 5.340

4.  Mediators of the inflammation induced in the rat paw by carrageenin.

Authors:  P Crunkhorn; S C Meacock
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

5.  Evaluation of antidiabetic, antioxidant and vasoprotective effects of Posidonia oceanica extract.

Authors:  Goksel Gokce; Mehmet Zeki Haznedaroglu
Journal:  J Ethnopharmacol       Date:  2007-09-25       Impact factor: 4.360

6.  TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse.

Authors:  Lauri J Moilanen; Mirka Laavola; Meiju Kukkonen; Riku Korhonen; Tiina Leppänen; Edward D Högestätt; Peter M Zygmunt; Riina M Nieminen; Eeva Moilanen
Journal:  Sci Rep       Date:  2012-04-24       Impact factor: 4.379

7.  Pimaradienoic Acid Inhibits Carrageenan-Induced Inflammatory Leukocyte Recruitment and Edema in Mice: Inhibition of Oxidative Stress, Nitric Oxide and Cytokine Production.

Authors:  Sandra S Mizokami; Miriam S N Hohmann; Larissa Staurengo-Ferrari; Thacyana T Carvalho; Ana C Zarpelon; Maria I Possebon; Anderson R de Souza; Rodrigo C S Veneziani; Nilton S Arakawa; Rubia Casagrande; Waldiceu A Verri
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

8.  Bioactive Compounds from Posidonia oceanica (L.) Delile Impair Malignant Cell Migration through Autophagy Modulation.

Authors:  Manuela Leri; Matteo Ramazzotti; Marzia Vasarri; Sara Peri; Emanuela Barletta; Carlo Pretti; Donatella Degl'Innocenti
Journal:  Mar Drugs       Date:  2018-04-21       Impact factor: 5.118

9.  Phaseolus vulgaris L. Extract: Alpha-Amylase Inhibition against Metabolic Syndrome in Mice.

Authors:  Laura Micheli; Elena Lucarini; Elena Trallori; Carmen Avagliano; Carmen De Caro; Roberto Russo; Antonio Calignano; Carla Ghelardini; Alessandra Pacini; Lorenzo Di Cesare Mannelli
Journal:  Nutrients       Date:  2019-08-01       Impact factor: 5.717

View more
  5 in total

1.  Formulation, Optimization and In Vivo Evaluation of Fucoidan-Based Cream with Anti-Inflammatory Properties.

Authors:  Ekaterina D Obluchinskaya; Olga N Pozharitskaya; Elena V Flisyuk; Alexander N Shikov
Journal:  Mar Drugs       Date:  2021-11-17       Impact factor: 5.118

2.  Unani Formulation Habb-e-Suranjan: A Treasure of Biological Activities.

Authors:  Ansari Imtiyaz Ahmed Tufail Ahemad; Qazi Majaz Ahamad Aejazuddin; G J Khan; Abdulrhman Alsayari; Shadma Wahab; Sharuk L Khan; Noor Jahan Akter; Md Rezaul Islam; Arpita Roy; Fahadul Islam
Journal:  Biomed Res Int       Date:  2022-07-26       Impact factor: 3.246

Review 3.  A Comprehensive Update on the Bioactive Compounds from Seagrasses.

Authors:  Christina Mutiara Putri Gono; Peni Ahmadi; Triana Hertiani; Eris Septiana; Masteria Yunovilsa Putra; Giuseppina Chianese
Journal:  Mar Drugs       Date:  2022-06-21       Impact factor: 6.085

4.  Glucose Uptake and Oxidative Stress in Caco-2 Cells: Health Benefits from Posidonia oceanica (L.) Delile.

Authors:  Camilla Morresi; Marzia Vasarri; Luisa Bellachioma; Gianna Ferretti; Donatella Degl Innocenti; Tiziana Bacchetti
Journal:  Mar Drugs       Date:  2022-07-14       Impact factor: 6.085

Review 5.  An Overview of New Insights into the Benefits of the Seagrass Posidonia oceanica for Human Health.

Authors:  Marzia Vasarri; Anna Maria De Biasi; Emanuela Barletta; Carlo Pretti; Donatella Degl'Innocenti
Journal:  Mar Drugs       Date:  2021-08-25       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.